Morphine sulphate 5 mg and placebo administered epidura//y after caesarean section under epidural analgesia were compared in a double-blind fashion. Morphine was significantly superior to placebo for pain relief, duration of pain relief, and reduction of parenteral narcotic requirements. Pruritis was the most commonly encountered sideeffect. There was no statistical difference between morphine and placebo in the incidence of urinary catheterisation, vomiting, nausea, dizziness or drowsiness. No serious respiratory depression requiring treatment was observed.
The administration of epidural narcotics to control pain has been the subject of much recent research following Behar and others' original repor1. 1 Most clinical reports have been favourable 2 -7 except for pain relief in labour. 8 ,lo Yu et al. 11 reported a double blind trial after caesarean section but his control group received morphine 4 mg intramuscularly at the time of administration of epidural placebo (saline).
This study was designed to evaluate the effects of a standard single dose of epidural morphine in the control of pain after caesarean section under epidural anaesthesia.
MATERIAL AND METHODS Fifty-two randomly selected patients undergoing elective caesarean section under epidural anaesthesia were studied. Informed consent was obtained from all patients.
One patient was excluded from the study as she returned to theatre six hours after caesarean section for evacuation of wound haematoma under general anaesthesia.
On the day before operation all patients were familiarised with a 20 cm visual analogue pain scale modified from Bond and Pilowsky12 and Beecher. 13 Each patient marked this line at 24 hours postoperatively at a point corresponding to the most severe pain they experienced during the preceding 24 hours.
All patients were premedicated with magnesium trisilicate 20 ml orally 15 minutes preoperatively. Epidural analgesia was performed at either L2-3 or L3-4 interspace using either bupivacaine plain 0.5OJo 20 ml (31 patients), or a mixture of lignocaine 2OJo 10 ml and bupivacaine 0.5OJo 10 ml (21 patients).
One hour after the operation, either morphine sulphate 5 mg in 0.1 OJo w Iv sodium metabisulphite 1 ml diluted to 5 ml in normal saline, or placebo O.IOJo w Iv sodium metabisulphite 1 ml diluted to 5 ml in normal saline was administered via the epidural catheter.
The ampoules were numbered and coded from 1 to 52 in a randomised double-blind method. Neither the morphine sulphate nor the placebo solution contained preservative other than 0.1 OJo wlv sodium metabisulphite. Each patient was informed at the time of administration of the morphine sulphate or placebo epidurally that they could obtain intramuscular narcotic (papaveretum 0.25-0.3 mg/kg body weight 4 hourly if required) pain relief on request.
At 24 hours after the administration of the morphine sulphate or placebo the following information was obtained. Each patient quantitated her pain at its most severe during the preceding 24 hours on the pain scale. The time of administration of the first parenteral narcotic was noted as was the number of narcotic doses required in the first 12 and 24 hours postoperatively.
This method of pain scoring at 24 hours after administration of the morphine or placebo was chosen because the duration of analgesia obtained was considered one of the major potential benefits of epidurally administered opiates. In current practice most general ward patients receive analgesia on demand, so this study attempted to interfere with the normal routine as little as possible.
The following parameters and their incidence were also obtained: vomiting, nausea, dizziness, drowsiness, paraesthesia, and incidence of postoperative urinary catheterisation in those patients unable to void spontaneously 6 hours postoperatively.
All patients were observed in the recovery room for 3 hours postoperatively and then discharged to the general ward.
Statistical methods
Pain score (Table 1) , duration of analgesia ( Table 2) , number of doses of analgesic at 12 hours and 24 hours postoperatively (Table 3) , and comparison of bupivacaine 0.5070 with lignocaine 2070 (Tables 4, 5 and 6) were analysed by the unpaired Student t test, while side effects ( Table 7) and urinary catheterisation were analysed using the Chi squared test.
RESULTS

Pain score
The results are shown in Table 1 . There was a significant reduction in postoperative pain in 
Postoperative narcotic requirements
Ten patients did not require narcotic analgesics postoperatively, two from the placebo group and eight from the morphine group.
The time from administration of either morphine sulphate or placebo epidurally, to the time of the first narcotic analgesic dose was noted in the remaining 41 patients. The duration of analgesia in the morphine sulphate group was significantly longer than in the placebo group (p < 0.01) ( Table 2 ). 
Postoperative doses of narcotic analgesic
The morphine sulphate group compared to the placebo group required significantly fewer narcotic analgesic doses, both at 12 hours and 24 hours postoperatively (p < 0.01). Results are shown in Table 3 . Comparing patients who received epidural morphine with those who received the placebo, there was no significant difference in the postoperative pain score ( Table 4) , duration of analgesia (Table 5 ), or number of doses of parenteral narcotic required (Table 6 ) between patients who received bupivacaine 0.5070 20 ml and those who received bupivacaine 0.5070 10 ml with lignocaine 10 ml mixture.
Parity and previous caesarean section
There were 8 primiparous and 18 multiparous patients in the morphine group of TABLE 4 Comparison of visual analogue pain scores of rhose parienls who received bupivacaine 0.5% 20 ml for caesarean secrion with those who received a lI1ixllIre of bupivacaine 0.5%, 101111 and lignocaine 2%, 10 ml Comparison of duration of analgesia in those parienrs who received bupivacaine 0.5%, 20 ml for caesarean secrion with that in parienrs who received a mixrure of bupivacaine 0.5%, 101111 and lignocaine 2% Comparison of rhe number of doses of intramuscular papaveretwn administered in the first 24 hours after operarion to patients having epidural bupivacaine 0.5% /0 ml for caesarean section with that administered to patients who received a mixture of bupivacaine 0.5% 10 ml and lignocaine 2% There was no significant difference using the chi squared test between primiparous or multiparous patients within each group on pain score, or doses of narcotic analgesic required at 12 and 24 hours postoperatively. Nausea and vomiting Nine patients were nauseated in the placebo group while fifteen patients were nauseated in the morphine group.
Eight patients vomited postoperatively in the placebo group while fifteen patients vomited in the morphine group. This represents an almost double incidence of nausea and vomiting in the morphine group as opposed to the placebo group which may be statistically significant in a larger trial.
Urinary catheterisation
Eleven patients in the morphine group and four patients in the placebo group required bladder catheterisation postoperatively. Using the Chi squared test this was not significant, but as the incidence of urinary catheterisation in the morphine group was almost double that in the placebo group, this may be significant in a larger trial.
Pruritis
Six patients out of 26 developed pruntls in the morphine group giving an incidence of 23070. In none of these patients was the pruritis segmentally localised but was over the trunk and limbs as well as the face in two patients. There were no cases of pruritis in the placebo group.
Respiratory depression
No serious respiratory depression requiring treatment was observed. However, none of these patients received a narcotic premedication. These patients were younger and fitter than those described by Boas l4 and may account for the absence of respiratory depression in this group.
DISCUSSION
Epidural narcotics including morphine have recently been the subject of considerable research. In this study we decided to first establish the efficacy of this technique by Anaesthesia and Intensive Care, Vol. 11, No. 2, Muy. 1983 controlled double-blind trial. Yu et al. 11 reported a double-blind trial after caesarean section but his control group received morphine 4 mg intramuscularly at the time of administration of epidural placebo (saline). He found that morphine 4 mg epidurally in 0.040/0 solution but not 0.02% solution was significantly superior to intramuscular morphine 4 mg for pain relief following caesarean section. There were only 7 patients in each group.
At the time of administration of the epidural drug one hour postoperatively, all patients had regression of their sensorineural blockade. Magora et al. 6 reported the efficacy of 3 mg doses of morphine in relieving pain but as these patients were unpremedicated a dose of morphine 5 mg sulphate was selected. Bromage et aC required a higher morphine dose from 7.6 mg to 10.3 mg but he was dealing with more painful procedures, such as upper abdominal surgery.
Boas l4 reports a high incidence of side effects at 50% including one cardiorespiratory arrest. All our patients were nursed in the general ward after the usual 3 hour postoperative stay in the recovery room. No cases of drowsiness or serious respiratory depression were observed.
Magora et al. 6 reported transient retention in three patients out of 98, while Torda et al. 4 ,ls stated it was a cause of discomfort rather than a real problem which was reflected in their clinical experience.
This study had a high incidence of catheterisation both in the placebo -4 out of 25 (16%) and 11 out of 26 (42%) in the morphine group.
There was no significant difference in the incidence of nausea, vomiting, dizziness and drowsiness between the morphine and placebo groups.
Itching was a nuisance problem in the morphine group with an incidence of 23 % similar to that reported by Weddel et al. 16 and Torda et al. 4 However, it was not confined to the epidural affected area confirming the results of Bromage and others,7,17 but contrary to the experience of Torda et al. 4 Large doses of antihistamines were found to relieve the itch but there was no rash or other sign of histamine release in any of the patients. Because the placebo contained 0.1 % w/v sodium metabisulphite, and there were no cases of pruritis in this group, I concur with Torda et al,4 that the itch is due to morphine sulphate.
In conclusion morphine sulphate 5 mg administered epidurally was significantly better than placebo for postoperative pain, duration of analgesia, and reduction of postoperative parenteral narcotic requirements after caesarean section under epidural anaesthesia. Pruritis was the only significant troublesome side effect although there was a high incidence of urinary catheterisation in both groups.
